The success of Sildenafil initially sparked a period of growth for the drug industry, but recent shifts present a murky picture for investors. Off-patent alternatives are eating into profits, and continued patent https://ezekielccre092139.blogproducer.com/48957722/the-blue-pill-and-pharma-a-volatile-investment